EGFR and intrahepatic cholangiocarcinoma: Furthermore, it has recently been demonstrated that YTHDF1 enhances the translation efficiency of epidermal growth factor receptor (EGFR) mRNA through its m6A reader function, thereby promoting the progression of intrahepatic cholangiocarcinoma [40].